Con: Cyclophosphamide for the treatment of lupus nephritis

Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis

(2016) Manish Rathi et al.   KIDNEY INTERNATIONAL

Multitarget Therapy for Induction Treatment of Lupus Nephritis

(2015) Zhihong Liu et al.   ANNALS OF INTERNAL MEDICINE

Long-term follow-up of theMAINTAINNephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis

(2015) Farah Tamirou et al.   ANNALS OF THE RHEUMATIC DISEASES

Mycophenolate mofetil for lupus nephritis: an update

(2015) Chi Chiu Mok   Expert Review of Clinical Immunology

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

(2014) Chi Chiu Mok et al.   ANNALS OF THE RHEUMATIC DISEASES

Emerging biological therapies for systemic lupus erythematosus

(2014) Chi Chiu Mok   EXPERT OPINION ON EMERGING DRUGS

Systemic Lupus Erythematosus and Malignancies

(2014) Basile Tessier-Cloutier et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study

(2014)   Arthritis & Rheumatology

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids

(2013) Marie B Condon et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus

(2013) C. C. Mok et al.   ARTHRITIS AND RHEUMATISM

Using cyclophosphamide in inflammatory rheumatic diseases

(2013) Tobias Brummaier et al.   European Journal of Internal Medicine

Cancer risk in systemic lupus: An updated international multi-centre cohort study

(2013) Sasha Bernatsky et al.   JOURNAL OF AUTOIMMUNITY

Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study

(2013) CC Mok et al.   LUPUS

Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis

(2013) W Kittanamongkolchai et al.   LUPUS

Overview of lupus nephritis management guidelines and perspective from Asia

(2013) Chi Chiu Mok et al.   NEPHROLOGY

Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials

(2012) Lorna K. Henderson et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

(2012) George K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus

(2012) C. C. Mok et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis

(2012) D. Y. H. Yap et al.   RHEUMATOLOGY

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

(2012) Bevra H. Hahn et al.   ARTHRITIS CARE & RESEARCH

Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis

(2011) Suzanne Arends et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides

(2011) Guillaume Le Guenno et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis

(2011) M Zeher et al.   LUPUS

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

(2011) Mary Anne Dooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial

(2010) Wei Chen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Efficacy and Cytokine Modulating Effects of Tacrolimus in Systemic Lupus Erythematosus: A Review

(2010) Kam Hon Yoon   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Efficacy and Adverse Events of Mycophenolate Mofetil Versus Cyclophosphamide for Induction Therapy of Lupus Nephritis

(2010) Nanticha Kamanamool et al.   MEDICINE

Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases

(2010) J. Cortes-Hernandez et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Minimal mesangial lupus nephritis: a systematic review

(2010) CC Mok et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

(2009) F A Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma

(2009) Chi Chiu Mok   Nature Reviews Nephrology

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

(2008) Christian Faul et al.   NATURE MEDICINE

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study

(2007) S Bernatsky et al.   ANNALS OF THE RHEUMATIC DISEASES